Your browser doesn't support javascript.
loading
The researcher's guide to selecting biomarkers in mental health studies.
Verhoeven, Josine E; Wolkowitz, Owen M; Barr Satz, Isaac; Conklin, Quinn; Lamers, Femke; Lavebratt, Catharina; Lin, Jue; Lindqvist, Daniel; Mayer, Stefanie E; Melas, Philippe A; Milaneschi, Yuri; Picard, Martin; Rampersaud, Ryan; Rasgon, Natalie; Ridout, Kathryn; Söderberg Veibäck, Gustav; Trumpff, Caroline; Tyrka, Audrey R; Watson, Kathleen; Wu, Gwyneth Winnie Y; Yang, Ruoting; Zannas, Anthony S; Han, Laura K M; Månsson, Kristoffer N T.
Affiliation
  • Verhoeven JE; Department of Psychiatry, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Wolkowitz OM; Amsterdam Public Health, Mental Health program, Amsterdam, The Netherlands.
  • Barr Satz I; Department of Psychiatry and Behavioral Sciences, and Weill Institute for Neurosciences, University of California San Francisco School of Medicine, San Francisco, California, USA.
  • Conklin Q; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.
  • Lamers F; Center for Mind and Brain, University of California, Davis, California, USA.
  • Lavebratt C; Center for Health and Community, University of California, San Francisco, California, USA.
  • Lin J; Department of Psychiatry, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Lindqvist D; Amsterdam Public Health, Mental Health program, Amsterdam, The Netherlands.
  • Mayer SE; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Melas PA; Center for Molecular Medicine, L8:00, Karolinska University Hospital, Stockholm, Sweden.
  • Milaneschi Y; Department of Biochemistry and Biophysics, University of California, San Francisco, California, USA.
  • Picard M; Unit for Biological and Precision Psychiatry, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Rampersaud R; Office for Psychiatry and Habilitation, Psychiatry Research Skåne, Region Skåne, Lund, Sweden.
  • Rasgon N; Department of Psychiatry and Behavioral Sciences, and Weill Institute for Neurosciences, University of California San Francisco School of Medicine, San Francisco, California, USA.
  • Ridout K; Center for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Söderberg Veibäck G; Department of Psychiatry, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Trumpff C; Amsterdam Public Health, Mental Health program, Amsterdam, The Netherlands.
  • Tyrka AR; Amsterdam Neuroscience, Complex Trait Genetics, Amsterdam, The Netherlands.
  • Watson K; Department of Psychiatry, Division of Behavioral Medicine, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, USA.
  • Wu GWY; Department of Neurology, H. Houston Merritt Center, Columbia Translational Neuroscience Initiative, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, USA.
  • Yang R; New York State Psychiatric Institute, New York, USA.
  • Zannas AS; Robert N Butler Columbia Aging Center, Columbia University Mailman School of Public Health, New York, New York, USA.
  • Han LKM; Department of Psychiatry and Behavioral Sciences, and Weill Institute for Neurosciences, University of California San Francisco School of Medicine, San Francisco, California, USA.
  • Månsson KNT; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.
Bioessays ; 46(10): e2300246, 2024 Oct.
Article in En | MEDLINE | ID: mdl-39258367
ABSTRACT
Clinical mental health researchers may understandably struggle with how to incorporate biological assessments in clinical research. The options are numerous and are described in a vast and complex body of literature. Here we provide guidelines to assist mental health researchers seeking to include biological measures in their studies. Apart from a focus on behavioral outcomes as measured via interviews or questionnaires, we advocate for a focus on biological pathways in clinical trials and epidemiological studies that may help clarify pathophysiology and mechanisms of action, delineate biological subgroups of participants, mediate treatment effects, and inform personalized treatment strategies. With this paper we aim to bridge the gap between clinical and biological mental health research by (1) discussing the clinical relevance, measurement reliability, and feasibility of relevant peripheral biomarkers; (2) addressing five types of biological tissues, namely blood, saliva, urine, stool and hair; and (3) providing information on how to control sources of measurement variability.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Mental Health Limits: Humans Language: En Journal: Bioessays Journal subject: BIOLOGIA / BIOLOGIA MOLECULAR Year: 2024 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Mental Health Limits: Humans Language: En Journal: Bioessays Journal subject: BIOLOGIA / BIOLOGIA MOLECULAR Year: 2024 Type: Article Affiliation country: Netherlands